Epoprostenol
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Epoprostenol and local guidelines before prescribing.
Prostacyclin
Mechanism
Prostacyclin.
Uses
Pulmonary arterial hypertension, dialysis anticoagulation alternative.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Flushing, headache, jaw pain, hypotension.
Interactions
Antihypertensives; anticoagulants.
Contraindications and cautions
Heart failure with severe left ventricular dysfunction
Monitoring
BP
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
Continuous central infusion; abrupt interruption risks rebound hypertension.
More from the textbook: uses, cautions and other points
- Prostacyclin pathway - epoprostenol (continuous IV infusion - line infections, rebound if interrupted), iloprost (inhaled), treprostinil, selexipag (oral receptor agonist).
Respiratory: Anatomy, Physiology and Pharmacology - Sildenafil / bosentan / epoprostenol | Pulmonary arterial hypertension (specialist); no nitrates with sildenafil; bosentan - liver, teratogenic.
Respiratory: Anatomy, Physiology and Pharmacology - Prostacyclin pathway - oral selexipag; inhaled iloprost; continuous IV or subcutaneous epoprostenol or treprostinil for severe disease.
Respiratory: Pulmonary Vascular Disease - Prostacyclin pathway (selexipag, iloprost, epoprostenol, treprostinil) | PAH (specialist); IV epoprostenol for severe disease - line infections, rebound if interrupted.
Respiratory: Pulmonary Vascular Disease - Pulmonary arterial hypertension - endothelin receptor antagonists (bosentan, ambrisentan, macitentan), PDE5 inhibitors (sildenafil, tadalafil), riociguat, prostacyclin analogues (iloprost, epoprostenol, selexipag); oxygen, diuretics, anticoagulation in some (see the Respiratory chapters).
Rheumatology: Connective tissue diseases
Where it is discussed in the book
- Respiratory: Anatomy, Physiology and Pharmacology (2 mentions)
- Respiratory: Pulmonary Vascular Disease (2 mentions)
- Respiratory: Sleep and Breathing (Complete) (1 mention)
- Rheumatology: Connective tissue diseases (1 mention)
- Integrated respiratory chapter (2 mentions)